Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma

BACKGROUND: Adriamycin (doxorubicin) is an important traditional drug that exhibits cytotoxicity in Diffuse Large B-cell Lymphoma (DLBCL). Doxorubicin affects the DLBCL cells at all stages of their cell cycle. Combined with our previous results, this study discovered that the overexpression of hsa-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Shufang, Shang, Qinyu, Zhu, Haipeng, Chen, Ken, Li, Xinxia, Gao, Hongliang, Liu, Bo, Feng, Mei, Gao, Lixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300279/
https://www.ncbi.nlm.nih.gov/pubmed/35873635
http://dx.doi.org/10.1155/2022/4290994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300279/
https://www.ncbi.nlm.nih.gov/pubmed/35873635
http://dx.doi.org/10.1155/2022/4290994

Ejemplares similares